首页> 中文期刊> 《中华医学杂志(英文版)》 >Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease

Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease

         

摘要

Background:Amyloid β (Aβ) has been established as a key factor for the pathological changes in the brains of patients with Alzheimer's disease (AD),and cellular senescence is closely associated with aging and cognitive impairment.However,it remains blurred whether,in the AD brains,Aβ accelerates the neuronal.senescence and whether this senescence,in turn,impairs the cognitive function.This study aimed to explore the expression of senescence-associated genes in the hippocampal tissue from young to aged 5XFAD mice and their age-matched wild type (WT) mice to determine whether senescent neurons are present in the transgenic AD mouse model.Methods:The 5XFAD mice and age-matched wild type mice,both raised from 1 to 18 months,were enrolled in the study.The senescence-associated genes in the hippocampus were analyzed and differentially expressed genes (DEGs) were screened by quantitative real-time polymerase chain reaction.Cognitive performance of the mice was evaluated by Y-maze and Morris water maze tests.Oligomeric Aβ (oAβ) (1-42) was applied to culture primary neurons to simulate the in vivo manifestation.Aging-related proteins were detected by Western blotting analysis and immunofluorescence.Results:In 5XFAD mice,of all the DEGs,the senescence-associated marker p 16 was most significantly increased,even at the early age.It was mainly localized in neurons,with a marginal expression in astrocytes (labeled as glutamine synthetase),nil expression in activated microglia (labeled as Iba1),and negatively correlated with the spatial cognitive impairments of 5XFAD mice.oAβ (1-42) induced the production of senescence-related protein p 16,but not p53 in vitro,which was in line with the in vivo manifestation.Conclusions:oAβ-accelerated neuronal senescence may be associated with the cognitive impairment in 5XFAD mice.Senescence-associated marker p 16 can serve as an indicator to estimate the cognitive prognosis for AD population.

著录项

  • 来源
    《中华医学杂志(英文版)》 |2016年第15期|1835-1844|共10页
  • 作者单位

    Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China;

    Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China;

    Key Laboratory of Brain Aging and Neurodegenerative Diseases, Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou,Fujian 350001, China;

    Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China;

    Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China;

    Key Laboratory of Brain Aging and Neurodegenerative Diseases, Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou,Fujian 350001, China;

    Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China;

    Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China;

    Key Laboratory of Brain Aging and Neurodegenerative Diseases, Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou,Fujian 350001, China;

    Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China;

    Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China;

    Key Laboratory of Brain Aging and Neurodegenerative Diseases, Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou,Fujian 350001, China;

    Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China;

    Key Laboratory of Brain Aging and Neurodegenerative Diseases, Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou,Fujian 350001, China;

    Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China;

    Key Laboratory of Brain Aging and Neurodegenerative Diseases, Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou,Fujian 350001, China;

    Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China;

    Key Laboratory of Brain Aging and Neurodegenerative Diseases, Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou,Fujian 350001, China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号